OBELAB Revenue and Competitors

Seoul,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • OBELAB's estimated annual revenue is currently $5.5M per year.(i)
  • OBELAB's estimated revenue per employee is $251,000

Employee Data

  • OBELAB has 22 Employees.(i)
  • OBELAB grew their employee count by 5% last year.

OBELAB's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is OBELAB?

OBELAB is an integrated solution company specializing in high-resolution portable brain imaging systems based on near-infrared spectroscopy (NIRS) technology. Our target market is hospitals and brain related research labs in Korea, US and Europe. OBELAB은 2013년 6월에 카이스트 연구실 창업을 통해 설립된 스타트업으로, NIRS(Near-Infrared Spectroscopy, 근적외선분광분석)을 활용하여 초고해상도의 wearable뇌영상장비를 개발하고 2017년 5월 KFDA, 2020년 6월 CE 인증을 득하였습니다. 현재 한국, 미국, 유럽 등 세계시장을 대상으로 병원 및 연구소에 판매중이며 LB인베스트먼트, 카카오인벤처스, 인터베스트 등 누적 105억원의 투자를 유치하였고, 차별화된 기술력을 바탕으로 혁신적인 제품의 지속적인 개발을 통해서 환자 및 일반인들의 삶의 질을 향상시키는 데에 기여할 수 있는 기업이 되고자 합니다.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$5.5M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

OBELAB News

2022-04-06 - ‘There's no magic potion to get children from Oxfordshire care homes to living with family members’, warns councillor

Councillor Liz Brighouse OBE (Lab, Churchill & Lye Valley), deputy leader of Oxfordshire County Council and the cabinet member for children,...

2022-03-22 - Portable Brain Scanner Market Insights by Size, Status and ...

OBELAB Inc. is a privately held company established in 2013. The company develops functional brain imaging systems by using the functional near-...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.2M22-15%N/A
#2
$3.9M2222%N/A
#3
$3.4M225%N/A
#4
$3.4M240%N/A
#5
$2.5M250%N/A